期刊文献+

气管导管抗菌处理后在防治呼吸机相关性下呼吸道感染的临床应用 被引量:3

Antibacterial-processed Endotracheal Tube on Prevention of Ventilator Associated Lower Respiratory Infection
原文传递
导出
摘要 目的用简易有效的方法降低呼吸机相关性下呼吸道感染(VALRI)的发生。方法对入住综合重症监护病房有创呼吸机支持呼吸的患者随机分成研究组(气管导管抗菌处理组)和对照组,两组定期同步对导管内壁和下呼吸道分泌物进行细菌学检测,并记录患者机械通气时间、呼吸机相关性下呼吸道感染的出现时间、病死率。结果机械通气(MV)5 d内,研究组呼吸机相关性肺炎(VAP)、呼吸机相关性气管-支气管感染(VARI)的发生率(4.8%、8.4%)显著低于对照组(16.7%、22.6%,P<0.05);研究组VAP、VARI的发生时间〔(10.3±4.2)d、(9.4±3.0)d〕均晚于对照组〔(4.5±2.8)d(、4.0±2.4)d〕;研究组MV的时间(14±18)d短于对照组(22±20)d;研究组病死率(8.3%)低于对照组(20.2%),比较差异均有统计学意义(P<0.05);86.5%患者下呼吸道分泌物在检出病原菌前,气管导管内就检出了该病原菌。结论气管导管抗菌处理后可以降低早发VALRI的发生率,可以使VARI和VAP的发生时间延迟,缩短MV时间,降低病死率;包括气管导管抗菌处理在内的优化捆绑治疗措施是防治VALRI的最佳策略。 OBJECTIVE To reduce the occurrence of ventilator associated lower respiratory infection(VALRI) with the simple effective method. METHODS All studied patients who received mechanical ventilation(MV) in ICU were divided into the study group (antibacterial-processed endotracheal tube group) and the control group. Bacterial culture of samples from endotracheal tube inwall and lower respiratory tract were obtained periodically. The clinical data such as the duration of MV, the time of occurrence of VALRI, and the case fatality rate were recorded and analyzed. RESULTS In patients with MV〈5 days: the incidence of VAP and ventilator-associated respiratory infection(VARI) in the study group (VAP: 4.8% and VARI: 8. 4% )were lower than those in the control group (VAP:16.7% and VARI:22. 6%,P〈0.05). The onset of VAP and VARI was delayed in the study group [VAP: (10.3± 4.2)d and VARI: (9.4±3.0)d) as compared with the control group [VAP: (4.5± 2.8)d and VARI:(4.0±2.4)d,P〈0.05]. The MV time of the study group (14±18) d was shorten than the control group (22±20) d. The mortality of the study group (8.3%) was lower than that of the control group (20.2%). There were singnificant statistical differences between them. The same organism that previously found from endotracheal tube inwall was existed in the next lower respiratory tract secretion in 86. 5% patients. CONCLUSIONS The usage of antibacterial-processed endotracheal tube can reduce the MV time, the mortality rate and the incidence of VAP and VARI in patients with MV〈5 d. The onset of VARI and VAP is delayed in the study group compared with the control group. The optimized bundle treatment including antibacterial-processed endotracheal tube is the best strategy for preventing and controlling VALRI.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2009年第16期2118-2120,共3页 Chinese Journal of Nosocomiology
关键词 气管导管抗菌处理 呼吸机相关性下呼吸道感染 优化捆绑治疗 机械通气 Antibacterial-processed endotracheal tube Ventilator associated lower respiratory infection Optimized bundle treatment Mechanical ventilation
  • 相关文献

参考文献5

二级参考文献39

  • 1于润江.呼吸道的生物被膜病[J].中华内科杂志,1993,32(5):291-292. 被引量:24
  • 2[1]Costeton JW, Chen KJ, Geesey GG, et al. Bacterial biofilms in nature and disease[J]. Ann Rev Microbiol, 1987,41:435-464
  • 3[2]Mah TF,O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents[J]. Trends Microbiol, 2001,9: 34-39
  • 4[3]Xu KD,McFeters GA,Stewart PS. Biofilm resistance to antimierobial agents[J]. Microbiology. 2000,146:547-549
  • 5[4]Ashiby MJ,Neale JE, Knott SJ,et al. Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli[J].J Antimicrob Chemother,1994,33:443-452
  • 6[6]YanagiharaK, Tomono K, Sawai T,et al. Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofiom formation [J]. J Antimicrob Chemother ,2000,46:69-72
  • 7[8]Ohgaki N. Bacterial biofilm in chronic airway infection [J].Kansehogaku Zasshi, 1994,68:138-151
  • 8[10]Costerton JW. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection[J]. Trends Microbiol..2001 ,9: 50-52
  • 9[12]Soboh F,Khoury AE, Zamboni AC,et al. Effects of ciprofloxacin and protamine sulfate combinations against catheter-associated pseudomonas aeruginosa biofilms[J]. Antimicrob Agents Chemother, 1995 ,39:1281-1286
  • 10[13]Gacesa P. Bacteria alginate biosynthesis-recent progress and future prospects[J]. Microbiology, 1998,144:1133-1143

共引文献1070

同被引文献52

  • 1American Thoracic Society, Infections Diseases Society of America. Guidelines for the management of adults with hospital acquired, ventilator associated, and healthcare associated pneumonia[J]. Am J Respir Crit Care Med, 2005,171(4) : 388-416.
  • 2Ratnawatis, Morton J, Henry RL, et al. Exhaled breath con- densate nitrite/nitrate and pH in relation to pediatric asthma control and exhaled nitric oxide[J]. Pediatric Pulmonol,2006, 41(10) :929-936.
  • 3Sousa C,Henriques M,Oliveira R.Mini-review:antimicrobial central venous catheters-recent advances and strategies[J].Biofouling,2011,27(6):609-620.
  • 4Bookstaver PB,Williamson JC,Tucker BK,et al.Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections[J].Ann Pharmacother,2009,43(2):210-219.
  • 5Mermel LA,Allon M,Bouza E,et al.Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection:2009update by the Infectious Diseases Society of America[J].Clin Infect Dis,2009,49(1):1-45.
  • 6Maki DG,Stolz SM,Wheeler S,et al.Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter.A randomized,controlled trial[J].Ann Intern Med,1997,127(4):257-266.
  • 7Raad I,Reitzel R,Jiang Y,et al.Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria[J].J Antimicrob Chemother,2008,62(4):746-750.
  • 8Darouiche RO,Raad II,Heard SO,et al.A comparison of two antimicrobial-impregnated central venous catheters.Catheter Study Group[J].N Engl J Med,1999,340(1):1-8.
  • 9Marik PE,Abraham G,Careau P,et al.The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters[J].Crit Care Med,1999,27(6):1128-1131.
  • 10Chaiyakunapruk N,Veenstra DL,Lipsky BA,et al.Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care:a meta-analysis[J].Ann Intern Med,2002,136(11):792-801.

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部